Top Insider Buys Highlight for the Week of Jan. 17
Insiders invest in JPMorgan, Simply Good Foods, Eiger BioPharmaceuticals and Geron Continue reading… …read more […]
Insiders invest in JPMorgan, Simply Good Foods, Eiger BioPharmaceuticals and Geron Continue reading… …read more […]
(Bloomberg) — Sign up here to receive the Davos Diary, a special daily newsletter that will run from Jan. 20-24.Libya’s biggest oil field began to halt production after armed forces shut down a pipeline, compounding supply disruptions that are continuing after a conference that aimed to broker an end to the OPEC nation’s civil war concluded in Berlin. The country’s oil production will be limited to 72,000 barrels per day once its storage tanks are full, according to a spokesman for the National Oil Corporation, down from more than 1.2 million barrels per day on Saturday. That’s the lowest level …read more […]
Mexico should move to deepen its economic ties with China after U.S. congressional approval of a new North American trade deal, a senior Mexican official said late on Saturday.
Venezuela’s economic and humanitarian crisis continues as Maduro clings onto power, but his latest attempt to seize full control of the oil & gas industry has been fruitless …read more […]
U.S. electric car pioneer Tesla has agreed to buy a property on the outskirts of Berlin, bringing it a step closer to opening its first European factory, local authorities said on Sunday.
U.S. electric car pioneer Tesla has agreed to buy a property on the outskirts of Berlin, bringing it a step closer to opening its first European factory, local authorities said on Sunday. The U.S. carmaker last November announced plans to build a giant factory in Gruenheide, in the eastern German state of Brandenburg, giving it the coveted “Made in Germany” label just as local rivals prepare to launch competing models. Tesla’s board of directors approved a purchase agreement with the state of Brandenburg on Saturday to acquire a 300-hectare property, Brandenburg government spokesman Florian Engels said in …read more […]
U.S. stock markets are closed Monday to observe Martin Luther King Jr.’s birthday. …read more […]
European industrial policy chief Thierry Breton dismissed claims that relying on European companies to build a 5G network would delay its rollout, weighing in on an increasingly tense debate in Germany over the risk posed by China’s Huawei.
For some taxpayers, returns have become easier to prepare and file but various problems linger, including with the Internal Revenue Service. …read more […]
The Internal Revenue Service has added tweaks to offer consumer protections to the ‘Free File’ program for the tax season, which kicks off Jan. 27. …read more […]
Growth is the name of the game, of course; it’s the surest way for investors to get the returns they demand. And from a growth perspective, last year was a banner year. The three main indexes – the Dow Jones, the S&P 500, and NASDAQ – all finished the year with strong gains, ranging from 22% on the Dow to the NASDAQ’s 35%.We’re seeing that brisk growth continue this month, as the indexes are starting 2020 with gains between 2.8% and 4.6%. Even with some obvious headwinds brewing – the chaos of a U.S. presidential election year with a deeply …read more […]
Yahoo Finance’s Brian Cheung explains P/E ratio. …read more […]
Reports from Netflix, Intel and Texas Instruments next week may hint at what is to come in the December quarterly earnings season, with some investors wary of possible danger signs that could knock Wall Street after its latest surge to record highs. The S&P 500 has gotten off to a strong start in January, up 3% so far this year, fueled by a truce in the U.S.-China trade war, low interest rates and signs the economy remains healthy. Analysts on average expect reports to show S&P 500 earnings per share fell 0.8% in the fourth quarter, with technology …read more […]
Bank OZK (NASDAQ:OZK) shares fell 3.9% to US$29.25 in the week since its latest yearly results. Revenues came in 2.7… …read more […]
Biotech stocks require only a few select indicators to send a share price soaring, or conversely, to cause it to tumble mercilessly down the charts. An FDA decision or results from a clinical trial have the ability to impact the stock’s direction either way, often dramatically so.On the Street, though, the key is to see beyond the noise and recognize the inherent future potential a company presents. Ignore the price for the moment and concentrate on value, is an oft repeated mantra. Is the company on its way to solving previously solution-free problems? Is it cash strapped or financially secure? …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.